Insulin degludec is an ultra-long-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. ...
Insulin degludec is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.